ELUCIDA ONCOLOGY Trademark

Trademark Overview

On Monday, June 27, 2016, a trademark application was filed for ELUCIDA ONCOLOGY with the United States Patent and Trademark Office. The USPTO has given the ELUCIDA ONCOLOGY trademark a serial number of 87084658. The federal status of this trademark filing is REGISTERED as of Tuesday, October 27, 2020. This trademark is owned by Elucida Oncology, Inc.. The ELUCIDA ONCOLOGY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of oncological disorders and diseases
elucida oncology

General Information

Serial Number87084658
Word MarkELUCIDA ONCOLOGY
Filing DateMonday, June 27, 2016
Status700 - REGISTERED
Status DateTuesday, October 27, 2020
Registration Number6185407
Registration DateTuesday, October 27, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 9, 2018

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"ONCOLOGY"
Description of MarkThe mark consists of the word "ELUCIDA" with an arrow underneath extending in to the letter "O" of the word "ONCOLOGY".
Goods and ServicesPharmaceutical preparations for the treatment of oncological disorders and diseases
Translation of Words in MarkThe English translation of "ELUCIDA" in the mark is "ELUCIDATE".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 15, 2017
Primary Code005
First Use Anywhere DateThursday, November 30, 2017
First Use In Commerce DateFriday, November 30, 2018

Trademark Owner History

Party NameElucida Oncology, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852
Party NameElucida Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMonmouth Junction, NJ 08852
Party NameElucida Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 101634668

Trademark Events

Event DateEvent Description
Tuesday, October 27, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, September 23, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 22, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, September 11, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 26, 2020USE AMENDMENT FILED
Friday, September 11, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 26, 2020TEAS STATEMENT OF USE RECEIVED
Thursday, February 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 11, 2020EXTENSION 4 GRANTED
Tuesday, February 11, 2020EXTENSION 4 FILED
Tuesday, February 11, 2020TEAS EXTENSION RECEIVED
Friday, August 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2019EXTENSION 3 GRANTED
Wednesday, August 14, 2019EXTENSION 3 FILED
Wednesday, August 14, 2019TEAS EXTENSION RECEIVED
Tuesday, February 26, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 22, 2019EXTENSION 2 GRANTED
Friday, February 22, 2019EXTENSION 2 FILED
Friday, February 22, 2019TEAS EXTENSION RECEIVED
Saturday, September 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 30, 2018EXTENSION 1 GRANTED
Thursday, August 30, 2018EXTENSION 1 FILED
Thursday, August 30, 2018TEAS EXTENSION RECEIVED
Tuesday, April 3, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 9, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 30, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 15, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 15, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 11, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 3, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 23, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 23, 2017NON-FINAL ACTION E-MAILED
Tuesday, May 23, 2017NON-FINAL ACTION WRITTEN
Tuesday, May 23, 2017REMOVED FROM TEAS PLUS
Monday, May 1, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 1, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 20, 2017ASSIGNED TO LIE
Wednesday, April 5, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 6, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 6, 2016NON-FINAL ACTION E-MAILED
Thursday, October 6, 2016NON-FINAL ACTION WRITTEN
Tuesday, October 4, 2016ASSIGNED TO EXAMINER
Friday, July 1, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, June 30, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 30, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

oncology elucida disorders diseases oncological treatment preparations pharmaceutical